<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Anal Chem</journal-id><journal-id journal-id-type="iso-abbrev">Anal Chem</journal-id><journal-id journal-id-type="publisher-id">ac</journal-id><journal-id journal-id-type="coden">ancham</journal-id><journal-title-group><journal-title>Analytical Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0003-2700</issn><issn pub-type="epub">1520-6882</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9453739</article-id><article-id pub-id-type="pmid">35994737</article-id><article-id pub-id-type="doi">10.1021/acs.analchem.2c02245</article-id><article-categories><subj-group><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Integrated
Metabolomic&#x02013;Genomic Workflows Accelerate
Microbial Natural Product Discovery</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="ath1"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3588-892X</contrib-id><name><surname>Avalon</surname><given-names>Nicole E.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath2"><name><surname>Murray</surname><given-names>Alison E.</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath3"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3033-5779</contrib-id><name><surname>Baker</surname><given-names>Bill J.</given-names></name><xref rid="cor3" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Chemistry, <institution>University of South Florida</institution>, Tampa, Florida 33620, <country>United States</country></aff><aff id="aff2"><label>&#x02021;</label>Division
of Earth and Ecosystem Sciences, <institution>Desert
Research Institute</institution>, Reno, Nevada 89512, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>navalon@ucsd.edu</email>.</corresp><corresp id="cor2"><label>*</label>Email: <email>Alison.Murray@dri.edu</email>.</corresp><corresp id="cor3"><label>*</label>Email: <email>bjbaker@usf.edu</email>.</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>08</month><year>2022</year></pub-date><pub-date pub-type="ppub"><day>06</day><month>09</month><year>2022</year></pub-date><volume>94</volume><issue>35</issue><fpage>11959</fpage><lpage>11966</lpage><history><date date-type="received"><day>25</day><month>05</month><year>2022</year></date><date date-type="accepted"><day>12</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac2c02245_0004" id="ab-tgr1"/></p><p>The pairing of analytical chemistry with genomic techniques
represents
a new wave in natural product chemistry. With an increase in the availability
of sequencing and assembly of microbial genomes, interrogation into
the biosynthetic capability of producers with valuable secondary metabolites
is possible. However, without the development of robust, accessible,
and medium to high throughput tools, the bottleneck in pairing metabolic
potential and compound isolation will continue. Several innovative
approaches have proven useful in the nascent stages of microbial genome-informed
drug discovery. Here, we consider a number of these approaches which
have led to prioritization of strain targets and have mitigated rediscovery
rates. Likewise, we discuss integration of principles of comparative
evolutionary studies and retrobiosynthetic predictions to better understand
biosynthetic mechanistic details and link genome sequence to structure.
Lastly, we discuss advances in engineering, chemistry, and molecular
networking and other computational approaches that are accelerating
progress in the field of omic-informed natural product drug discovery.
Together, these strategies enhance the synergy between cutting edge
omics, chemical characterization, and computational technologies that
pitch the discovery of natural products with pharmaceutical and other
potential applications to the crest of the wave where progress is
ripe for rapid advances.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>National Cancer Institute</institution><institution-id institution-id-type="doi">10.13039/100000054</institution-id></institution-wrap></funding-source><award-id>CA205932</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ac2c02245</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ac2c02245</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p id="sec1">Genomic approaches to drug discovery
have not only focused on the study of human genomes to better understand
protein targets, cellular cascades, drug resistance, epigenetics,
and their implications on human disease to further refine drug discovery
efforts,<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> but genomic studies have revealed a vast
repertoire of diversity in microbial metabolic innovation which can
also be paired with metabolomics for the study of microbially produced
secondary metabolites. Secondary metabolites have garnered great interest
as potential pharmaceuticals as the diverse chemical scaffolds are
well suited for biological targets.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Over
50% of FDA-approved medications have been sourced directly from or
inspired by nature.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup></p><p>Historically,
methods of natural product isolation and characterization
relied heavily on extraction of secondary metabolites from both microorganisms
and macroorganisms requiring time-intensive analytical procedures
for isolation and compound characterization. Over time, several barriers
to natural product discovery have been identified, such as high rediscovery
rates and the potential ecological impact of mass field collections,
with implications on the sustainability of the source. Technological
advances have now ameliorated most of these concerns. For example,
omics techniques have been harnessed to prioritize samples, quickly
identify metabolites of interest, and utilize genomic information
to inform natural product discovery.<sup><xref ref-type="bibr" rid="ref5">5</xref>&#x02212;<xref ref-type="bibr" rid="ref7">7</xref></sup> Technological advances
also enhance the potential for a more sustainable exploration of nature&#x02019;s
chemical wealth and for creation of an ongoing supply of compounds
through biotechnology.</p><p>One of the primary ways that genomics
is integrated with drug discovery
of natural products is by the identification of biosynthetic gene
clusters (BGCs). BGCs encode for the enzymatic machinery, ranging
in organization from single iteratively acting enzymes to multidomain
megaenzymes with numerous catalytic sites, that are responsible for
the biosynthesis of secondary metabolites.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> These discrete genomic elements are similar to, but evolutionarily
divergent from, genes involved in primary metabolism (i.e., polyketide
synthases are likely derive from fatty acid synthases). The genes
have been evolutionarily repurposed to produce an array of architecturally
diverse compounds under tight stereochemical controls with a strong
affinity toward biological targets. BGCs can be horizontally transferred
from one organism to another, a phenomenon that can be identified
through phylogenetic analysis, as the evolutionary history of clustered
elements within a BGC can be quite divergent from the remainder of
the genome.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup></p><p>Today, there is a wealth
of publicly accessible databases tailored
to the fields of genomics and natural products, some linking the two
disciplines, and several of which are community-curated with ongoing
contributions that serve as data resources (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Data sourced from these repositories are
often used in comparative analyses with a multitude of software tools
resulting in powerful analyses that are becoming more integrated due
to improvements in cross-communication between the fields and resources
available (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).
There were significant barriers in the past with databases having
little crosstalk, particularly between different disciplines and technologies
(e.g., biosynthetic gene cluster data with metabolomic profiles).
This divide demonstrates the importance of interdisciplinary collaborations
and community curation in natural product chemistry and is consistent
with the movement toward open-source software that evolves and incorporates
new tools and strategies.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>List of Resources and Accompanying
Website for Each of the Approaches Presented</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">Data resource</th><th style="border:none;" align="center">Website</th></tr></thead><tbody><tr><td colspan="2" align="left"><bold>Approach 1: Dereplication
at the genomic level</bold></td></tr><tr><td style="border:none;" align="left">NCBI</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</uri></td></tr><tr><td style="border:none;" align="left">BLAST</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://blast.ncbi.nlm.nih.gov">https://blast.ncbi.nlm.nih.gov</uri></td></tr><tr><td style="border:none;" align="left">AntiSMASH</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://antismash.secondarymetabolites.org">https://antismash.secondarymetabolites.org</uri></td></tr><tr><td style="border:none;" align="left">AntiSMASH-DB</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://antismashdb.secondarymetabolites.org">https://antismashdb.secondarymetabolites.org</uri></td></tr><tr><td style="border:none;" align="left">IMG/ABC</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://img.jgi.doe.gov/cgi-bin/abc/main.cgi">https://img.jgi.doe.gov/cgi-bin/abc/main.cgi</uri></td></tr><tr><td style="border:none;" align="left">MIBiG</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://mibig.secondarymetabolites.org">https://mibig.secondarymetabolites.org</uri></td></tr><tr><td colspan="2" align="left"><bold>Approach
2: Prioritization
based on microbial taxonomy</bold></td></tr><tr><td style="border:none;" align="left">BiG-SCAPE</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bigscape-corason.secondarymetabolites.org">https://bigscape-corason.secondarymetabolites.org</uri></td></tr><tr><td style="border:none;" align="left">CORASON</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/nselem/corason/wiki">https://github.com/nselem/corason/wiki</uri></td></tr><tr><td style="border:none;" align="left">NaPDoS</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://npdomainseeker.sdsc.edu">https://npdomainseeker.sdsc.edu</uri></td></tr><tr><td style="border:none;" align="left">AutoMLST</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://automlst.ziemertlab.com">https://automlst.ziemertlab.com</uri></td></tr><tr><td colspan="2" align="left"><bold>Approach
3: Coevolutionary
principles to guide discovery</bold></td></tr><tr><td style="border:none;" align="left">ARTS</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://arts.ziemertlab.com">https://arts.ziemertlab.com</uri></td></tr><tr><td style="border:none;" align="left">EvoMining</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/nselem/EvoMining/wiki">https://github.com/nselem/EvoMining/wiki</uri></td></tr><tr><td style="border:none;" align="left">CO-ED</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://enzyme-analysis.org">http://enzyme-analysis.org</uri></td></tr><tr><td colspan="2" align="left">Approach&#x000a0;4:&#x000a0;Retrobiosynthesis&#x000a0;to&#x000a0;target&#x000a0;biosynthetic&#x000a0;gene&#x000a0;clusters</td></tr><tr><td colspan="2" align="left"><bold>Approach 5: Molecular networking
to identify analogues</bold></td></tr><tr><td style="border:none;" align="left">GNPS</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gnps.ucsd.edu">https://gnps.ucsd.edu</uri></td></tr><tr><td colspan="2" align="left"><bold>Approach
6: Pairing enzymatic
domains with key structural features</bold></td></tr><tr><td style="border:none;" align="left">IsoAnalyst</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/liningtonlab/isoanalyst">https://github.com/liningtonlab/isoanalyst</uri></td></tr><tr><td colspan="2" align="left"><bold>Approach
7: Paired genome-metabolite
databases for discovery</bold></td></tr><tr><td style="border:none;" align="left">NRPminer</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/mohimanilab/NRPminer">https://github.com/mohimanilab/NRPminer</uri></td></tr><tr><td style="border:none;" align="left">PoDP</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pairedomicsdata.bioinformatics.nl">https://pairedomicsdata.bioinformatics.nl</uri></td></tr><tr><td style="border:none;" align="left">MetaMiner</td><td style="border:none;" align="left"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/mohimanilab/MetaMiner">https://github.com/mohimanilab/MetaMiner</uri></td></tr></tbody></table></table-wrap><p>The power of analytical chemistry in natural product
drug discovery
remains a critical element of the field. Traditional methods for isolation
and characterization of natural products, notably the use of chromatography,
mass spectrometry (MS), and nuclear magnetic resonance (NMR), are
a mainstay for structure isolation and characterization. When combined
with genome and metagenome-informed approaches, analytical techniques
are being used to advance the technological frontier of drug discovery.
Examples of these approaches are discussed below, and new approaches
are proposed that will continue to merge the fields of genomics and
metabolomics in a synergistic way to enhance natural product discovery
efforts.</p><sec id="sec2"><title>Context and Scope: Integration of Interdisciplinary Omics Approaches
to Advance Natural Product Discovery Efforts</title><p>In this perspective,
we explore emerging technologies and computational
tools that pair genomic and metabolomic data for natural product drug
discovery (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). What follows is a compilation of approaches (or workflows; <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>) that highlight the
synergy between genomics and analytical chemistry which will likely
continue to enhance and refine microbial natural product discovery
efforts. This is not meant to serve as a comprehensive overview of
all available tools and strategies as there are several reviews that
discuss mass spectral databases and genomic databases as well as tools
aimed at mining the big data resulting from both. We refer the reader
to those reviews for further information on the tools discussed here.<sup><xref ref-type="bibr" rid="ref5">5</xref>&#x02212;<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref11">11</xref>&#x02212;<xref ref-type="bibr" rid="ref13">13</xref></sup> The tools discussed
here were published before January 2022.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Workflows for integration
of genomic and metabolomic strategies
for natural product discovery.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac2c02245_0001" id="gr1" position="float"/></fig></sec><sec id="sec3"><title>Workflows for Integrated Approaches to Genome-Enabled Natural
Product Biodiscovery</title><sec id="sec3.1"><title>Approach 1: Dereplication at the Genomic Level to Reduce Rediscovery
Rates of Known Natural Products and Enhance Discovery of Novel Natural
Products</title><p>Dereplication of chemical structures, through detailed
comparison of NMR and MS data of an isolated compound to the scientific
literature and to chemical databases, is a long-standing strategy
to reduce rediscovery in the early phases of natural product isolation
process. A similar strategy can be employed for rapid dereplication
using genomic information. BGCs identified in new (meta)genome sequences
can be rapidly searched against global databases (e.g., NCBI)<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> in addition to more curated tools (e.g., AntiSMASH)<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> which assess homology across modules, genes,
and full length BGCs. Due to the exponentially increasing volume of
data, number of data repositories, and bioinformatic tools for known
BGCs, we are in a renaissance of natural product biodiscovery.</p><p>Basic Local Alignment Search Tool (BLAST)<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> searches have been a bioinformatic mainstay for comparing nucleotide
and protein sequence information through the detection of regions
of similarity between the inquiry sequence and a vast database of
biological sequences with a broad range of taxonomic representation.
There are innate limitations to BLAST searches for BGCs, however,
given the lengthy multidomain nature of these cassettes. BLAST searches
can help one gain a clearer understanding of the biosynthetic substructures;
however, the tool is not well suited for rapid identification or comparison
of entire BGCs or for unique and novel sequences.</p><p>The antiSMASH
BGC annotation pipeline<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> harbors annotations
of putative BGCs based on their identifications
using the antiSMASH algorithm. With over 150,000 putative BGCs, the
ClusterBlast algorithm nested within antiSMASH compares submitted
sequences to those in the database for analyses of fungal and bacterial
BGCs.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> The Integrated Microbial Genome
Atlas of Biosynthetic Gene Clusters (IMG/ABC)<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> contains over 400,000 BGCs. Further, gene cluster families, which
share similarities in gene structure, can be identified and visualized
using BiGSCAPE.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> In concert, these integrated
tools allow for rapid dereplication of genome-encoded BGC sequences
that are critical in the biosynthesis of natural products and enhance
the likelihood of discovery of not only new BGCs but also new secondary
metabolites.</p><p>Recently, the scientific community has developed
a common language
and data standard to communicate the biosynthetic gene cluster data
and associated chemistry. The standard, led by Kautsar and colleagues
and referred to as the Minimum Information about a Biosynthetic Gene
Cluster (MIBiG),<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> is accompanied by a
repository which houses nearly 2000 BGCs as of early 2022 (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). This resource
allows for manual curation and annotation by the natural product community
and the MIBiG developers. It serves as a centralized space to deposit
and access valuable data about BGCs including information on enzymatic
features, protein sequences, taxonomic origins, and associated chemical
structures. MIBiG has also been incorporated into antiSMASH<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> and is used to screen (meta)genomes submitted
for BGC analysis for similarity to known BGCs in the MIBiG database.
Beyond identification of identical BGCs and dereplication, the referencing
of the MIBiG repository within antiSMASH provides a percent identity
score for submitted BGCs affording the opportunity to utilize the
similarities in gene structure to target novel metabolites. On the
basis of the differences in the gene sequence, differences in chemical
structure can be inferred. This allows for rapid dereplication as
part of the antiSMASH genome mining pipeline. Metagenomic libraries
can therefore be efficiently interrogated for the presence of BGCs
and evaluated for homologies to known BGCs. This strategy can guide
prioritization of BGCs of interest for further investigation with
cultivation or biotechnological measures.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Nearly 500,000 BGCs have
been identified, of which 87,000 are derived
from metagenome-assembled genomes (MAGs). Of the identified natural
products, only 2000 have been paired with BGCs, and only five of those
are associated with metagenome-assembled genomes. Data obtained from
NP Atlas,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> IMG-ABC,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> MiBIG,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> and the GEM Catalog.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ac2c02245_0002" id="gr2" position="float"/></fig></sec><sec id="sec3.2"><title>Approach 2: Prioritization of Drug Discovery Efforts Based on
Biosynthetic Potential of Certain Microbial Taxa</title><p>Across the
immense diversity of the bacterial domain of life, the distribution
of biosynthetic gene clusters is only recently becoming understood.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Certain bacterial taxonomic families are known
to be more biosynthetically talented than others. However, biosynthetic
potential, the likelihood that secondary metabolites can be produced,
is understudied in many lineages. This makes the prospect for novelty
high, particularly in poorly studied lineages, many of which have
evaded cultivation. BGCs with low levels of similarity, in particular,
those associated with poorly known phylogenetic uniqueness, can be
used to mine novel BGCs and point to new compounds. Alternatively,
novelty remains to be discovered even in more familiar lineages including
two distinct bacterial groups that are known to be particularly rich
in BGCs and known to produce bioactive compounds (filamentous cyanobacteria
and <italic>Streptomyces</italic>). For example, Le&#x000e3;o and colleagues
characterized the biosynthetic potential based on BGC classes and
resultant metabolites from tropical filamentous marine cyanobacteria.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> They suggested that &#x0201c;natural product
diversity hotspots&#x0201d; should be prioritized, while ecosystems
or niches with low beta-diversity when paired with low numbers of
BGCs were deemed to be more likely to result in rediscovery of known
natural products.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Many of the FDA-approved
anti-infectives are derived from actinomycetes, specifically <italic>Streptomyces</italic> spp. There are several examples applying <italic>Streptomyces</italic>-targeted investigation that are yielding novelty.
Soldatou and colleagues specifically looked at the biosynthetic potential
residing within Arctic and Antarctic actinomycetes and, through extensive
cultivation efforts and the one strain&#x02013;many compounds (OSMAC)
method, were able to confirm high rates of both metabolic diversity
and anti-infective bioactivity.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> The microbial
diversity in Indonesian bacterial strains used a similar strategy
of linking genomic and metabolomic data to leverage biosynthetic talent
within their collection of <italic>Streptomyces</italic> spp. and
promote the discovery of novel natural products.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Each of these research teams utilized the Biosynthetic
Gene Similarity Clustering and Prospecting engine (BiG-SCAPE)<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> which groups BGCs into gene cluster families
based on sequence similarity networks. This software tool is now paired
with the CORe Analysis of Syntenic Orthologues to prioritize Natural
Product Gene Clusters (CORASON),<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> a tool
that defines phylogenetic relationships within gene cluster families.</p><p>Additional tools for rapid evaluation of biosynthetic potential
based on phylogeny and taxonomy include NaPDos and AutoMLST. The Natural
Product Domain Seeker (NaPDoS) can be used to identify biosynthetic
enzymes and therefore biosynthetic wealth, with a focus on PKS and
NRPS genes, in genomic and metagenomic data.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> This tool phylogenetically classifies condensation domains and ketosynthase
domains resulting in a phylogenetic tree of these domains with those
of known BGCs to help determine similarities with known biosynthetic
pathways. Another phylogenetic tool that can aid in determining biosynthetic
potential is the Automated Multi-Locus Species Tree (AutoMLST)<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> which builds phylogenetic trees from a simplified
user interface to infer relationships of bacteria from the users&#x02019;
collections. The output includes taxonomic clade information, and
data points can then be used to make inferences about the biosynthetic
potential of the associated species.</p><p>For laboratory groups with
extensive bacterial culture collections,
prioritization of strains based on their phylogenetic placement can
be key in streamlining drug discovery efforts. These strategies of
prioritization can be paired with targeted large-scale cultivation
efforts and subsequent natural product isolation and characterization
as well as biotechnological means to express specific BGCs for drug
discovery.</p></sec><sec id="sec3.3"><title>Approach 3: Use of Coevolutionary Principles to Guide Genome-Mining</title><p>Another valuable approach has been introduced by Ziemert and colleagues
through the Antibiotic Resistant Target Seeker (ARTS).<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> The software tool pairs algorithms to determine
phylogenic discrepancies which may indicate horizontal gene transfer,
with additional features such as gene duplication and proximity to
resistance markers that can be used to highlight those clusters that
may have an increased likelihood of producing anti-infective bioactive
molecules.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Although the initial version
was focused primarily on actinobacterial genomes, the release of the
second ARTS version in 2020 expanded the tool to allow for analysis
of genomes from all bacterial taxa as well as from metagenomic data.
Since bacteria have been found to harbor resistance genes integral
to the prevention of self-toxicity in genomic proximity to the secondary
metabolites they produce,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> this strategy
is a way to streamline genomic-based antibiotic discovery. These mechanisms
include, but are not limited to, pro-drug formation, other chemical
modification, use of efflux pumps, and self-resistant protein variants.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> Manual interrogation for specific markers not
yet included in ARTS 2.0 can be used to complement and expand the
search for relevant resistance genes. For example, glycosylation via
glycosyl transferases can be used for pro-drug formation and self-protection.<sup><xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref32">32</xref></sup></p><p>Additional tools utilize a targeted genome mining approach
through analyzing genomic data sets for proteins or enzymatic domains
that are believed to be a key part of biosynthesis; however, they
are not readily detected in the current algorithms for BGC identification.
For example, EvoMining<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> utilizes coevolutionary
principles for comparative genome mining based on &#x0201c;expansion-and-recruitment
events&#x0201d;, gene recruitment associated with signatures of rapid
evolution found as enzyme families. This tool has expanded BGC identification
and annotation substantially, particularly for those biosynthetic
enzymes that are not associated with PKS, NRPS, or hybrid PKS&#x02013;NRPS
systems, and are therefore more difficult to analyze than their more
modular counterparts.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup></p><p>Co-occurrence of tandem
enzyme domains has been used to identify
previously poorly annotated BGCs that are responsible for biosynthesis
of oxazolone-containing natural products.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> The aptly named Co-occurrence of Enzymatic Domains (CO-ED) workflow
developed by de Rond and colleagues is based on a genome mining approach
that focuses on the presence of a series of catalytic domains within
a protein that together perform a specific biochemical transformation.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> The workflow was successfully used to interrogate
a library of genomes to guide the functional annotation of a new oxazolone
synthetase, and subsequently, a suite of new oxazolone natural products
was characterized through MS and spectroscopic methods after heterologous
expression of the corresponding genes.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup></p></sec><sec id="sec3.4"><title>Approach 4: Retrobiosynthesis for Targeted BGC Identification
of Known Natural Products</title><p>Retrobiosynthetic analysis is the
process of determining likely biosynthetic steps based on biosynthetic
subunit precursors that comprise the molecule of interest. This analysis
can be used to identify if the BGC responsible for a compound of interest
is reasonable, particularly when colinear arrangement of genes and
enzymatic activity are suspected in the biosynthesis of a given product.
This type of modular organization is often seen in Type I PKS, NRPS,
and hybrid PKS&#x02013;NRPS systems. The secondary metabolites that
result from these classes of BGCs generally demonstrate colinearity,
meaning that the genomic code, enzymatic domains, and resultant chemical
structures are closely linked, conferring a degree of predictability.<sup><xref ref-type="bibr" rid="ref36">36</xref>&#x02212;<xref ref-type="bibr" rid="ref38">38</xref></sup> This colinearity can be harnessed to enhance drug discovery efforts.
Retrobiosynthetic strategies can predict the specific enzymatic domains
that would be responsible for creating a particular structural feature
or to match a known structure to the series of enzymatic domains within
a BGC. Modular organization of PKS and NRP systems makes them conducive
to biotechnological engineering and combinatorial biosynthesis. This,
combined with the tight stereospecific control promoted by the biosynthetic
enzymes for the architecturally complex natural products,<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> makes identification and expression of BGCs
particularly appealing.</p><p>As demonstrated by our group with palmerolide
biosynthesis,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> a retrobiosynthetic strategy
can be utilized to identify the BGC implicated in the biosynthesis
of a specific secondary metabolite out of a diverse metagenome represented
by many bacterial genomes. In the case of palmerolide A, key enzymatic
features were used to interrogate the metagenome from environmental
samples, and the modular arrangement of the biosynthetic pathway derived
from the retrobiosynthetic analysis was used to identify the putative
BGC. Identification of the BGC<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> and host-associated
microbial producer<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> now paves the way
for drug development efforts through biotechnological means (i.e.,
through heterologous expression or targeted cultivation efforts).
Other examples of BGC identification using similar strategies within
genomes of previously characterized polyketide compounds with potent
bioactivity include those for calyculin (cytotoxicity),<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup> corallopyronins (broad spectrum antibiotic activity),<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> and bryostatins (anticancer and neuroprotective activity).<sup><xref ref-type="bibr" rid="ref46">46</xref>&#x02212;<xref ref-type="bibr" rid="ref50">50</xref></sup> The implications for these strategies cross into the various compound
classes and can help propel compounds with pharmaceutical promise
through the drug discovery pipeline.</p></sec><sec id="sec3.5"><title>Approach 5: Use of Molecular Networking to Identify and Target
New Analogues Arising from the Same or Highly Similar BGCs</title><p>Tandem mass spectral data from bacterial cultures or environmental
samples can be analyzed in molecular networks via Global Natural Products
Social Molecular Networking (GNPS).<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Useful
for library searches for small molecules and peptides, for initial
dereplication, and to evaluate the tandem MS data in chemical space,
this increasingly robust tool is a powerful companion for drug discovery
efforts. Molecular networking can be paired with genomic workflows
for analogue molecule identification resulting from BGC expression,
whether in the native host or in a heterologous host. Due to the sequential
head-to-tail elongation steps that occur in a modular fashion in both
modular Type I PKS and NRPS systems, and the diversity introduced
by post-translational modifications to the established core sequence
within RiPPs, these biosynthetic systems are amenable to combinatorial
biosynthetic methods<sup><xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup> in which molecular networking
can be an efficient way of analyzing outcomes.</p><p>Molecular networking
can be used as a screening tool in novel bacterial cultivation efforts
to identify analogues of known natural products as well as to highlight
the presence of new metabolites arising from a single BGC. Using <italic>m</italic>/<italic>z</italic> differences between interconnected
nodes within a cluster, which represent distinct compounds based on
a consensus spectrum, structural differences among analogues can be
inferred. Alternately, clusters of related ions with no match to known
metabolites are indicative of new chemistry. In either case, MS-guided
isolation using mass-selective fractionation can be pursued to focus
purification strategies on the unknown masses.</p><p>Analogues can
be formed with heterologous expression of BGCs, as
seen with verticilactams,<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> as well as
after deletion or alteration of enzymatic domains within BGCs and
subsequent expression, as seen with the BGCs for complestatin and
lobophorin.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> Therefore, after synthetic biology
experiments, a molecular network can be used to visualize the biocombinatorial
chemical space through uploading the tandem mass spectral data of
the metabolites produced by the wild type producer and those that
arise from the synthetic biology experiments. A direct comparison
can be performed that includes confirmation of contribution to nodes
that represent the compound(s) of interest and an evaluation of new
nodes that may appear within a compound cluster, indicating new analogues.
The MS<sup>2</sup> fingerprints for nodes representing these additional
products can assist in structure elucidation and evaluation of the
underlying mechanisms for their biosynthesis. A similar strategy was
used following the expression of the alterchromide BGC<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> and the cosmomycin BGC<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> to identify previously undescribed analogues. More recently, molecular
networking aided in identification of the production of several new
herbicidin analogues following overexpression of the herbicidin BGC<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> and in a new acylhomoserine lactone (AHL) after
expression of an AHL synthase.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup></p></sec><sec id="sec3.6"><title>Approach 6: Use of Enzymatic Domains within BGCs to Identify
Key Structural Features of Unknown Products That Can Be Paired with
Analytical Tools</title><p>Following annotation of enzymatic domains
within a BGC, the presence of a number of domains can be used to identify
a previously unknown product or feature within a product, as some
metabolomic signatures on MS can be paired with functional enzymatic
annotations within BGCs. For example, if a halogenase is present in
a BGC, a halogenation signature on MS could be used for the isolation
of a halogenated natural product. In a similar manner, the metabolomic
signatures for sulfate, phosphate, and carbamate groups can be associated
with enzymatic domains such as sulfatases, phosphatases, and carbamoyl
transferases. These strategies have potential implications for discovery
of natural products and may also play a role in linking an orphan
BGC (BGC with no known product) within a bacterial genome to a previously
characterized compound containing a specific functional group or groups.</p><p>Harnessing the ability to identify isotopic patterns using NMR
and MS, isotopically labeled precursors as informed by BGCs, can be
used for natural product discovery. In the case of the orfamides,
the cultures of <italic>Pseudomonas fluorescens</italic> Pf-5 were
fed isotopically labeled amino acids that were selected based upon
adenylation domain specificity from the genomic information on an
orphan gene cluster. Isotope-guided fractionation using NMR (in parallel
with bioassay-guided fractionation) was utilized, and the structure
of orfamide A was determined through NMR experiments, GC-MS, and Marfey&#x02019;s
analysis.<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> Building upon the genomisotopic
approach, Gerwick and colleagues later enriched the media of cyanobacterial
cultures with <sup>15</sup>N-nitrate and performed repeated MALDI
experiments on single-filaments of <italic>Moorena producens</italic> JHB that allowed for the identification and subsequent isolation
of a new natural product, cryptomaldamide, through an MS-guided fractionation
approach.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> Full characterization was performed
through spectroscopic methods, and the compound&#x02019;s structure
was linked to a putative BGC based on genomic analysis. The 28.7 kbp
BGC for cryptomaldamide was subsequently heterologously expressed
in a genetically tractable host, <italic>Anabaena</italic> PCC, giving
further significance to this method of natural product discovery.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> Recently developed by Linington and colleagues,
the IsoAnalyst platform uses isotopic labeling of biosynthetic precursors
in parallel feeding experiments paired with MS to link BGCs to their
natural products.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> The platform utilizes
biosynthetic relatedness based on the isotopic patterns rather than
deriving structural information on fragments from the tandem mass
spectral data. Validated with erythromycin and its analogues, IsoAnalyst
was also used to discover a new lobosamide analogue and a new desferrioxiamine
compound from <italic>Micromonospora</italic> sp.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup></p></sec><sec id="sec3.7"><title>Approach 7: Harnessing Paired Genome&#x02013;Metabolite Data
Sets and Tools for Natural Product Discovery</title><p>Tools to link
BGCs and MS spectra have been developed, in particular, for NRPs.
Released by Behsaz and colleagues, NRPminer<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> pairs tandem mass spectral data with NRPS BGCs and builds upon previously
developed tools, such as NRP2 Path<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> and
NRPquest.<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> Through a series of steps which
integrate antiSMASH BGC identification from a sequenced genome,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> GNPS molecular networking of the associated
sample,<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> and VarQuest<sup><xref ref-type="bibr" rid="ref66">66</xref></sup> searches, a list of potential enzymatic assembly lines
is populated, filtered, overlaid with potential modifications, and
then used to predict possible backbone structures of NRPs. These predicted
structures are used to search the mass spectral data for matches that
are scored based upon similarity. NRPminer is different from other
tools for tandem MS and NRPS BGC pairing as it builds upon the principles
of collinearity, allows for broad adenylation domain specificity (including
duplication of open reading frames), and is flexible with respect
to diverse post-assembly modifications.</p><p>Recently, another resource
for pairing genomic and metabolomic data sets was released. The Paired
Omics Data Platform (PoDP)<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> is a community-curated
platform that links genomic or metagenomic data, metabolomic data,
and metadata regarding experimental details on culture, extraction,
and instrumentation methods. The purpose of the platform is not to
host the big data, but rather link the data that are deposited in
various public repositories (many of which have been described above)
in order to promote easy access to these carefully curated paired
data sets for large computationally driven projects or for smaller
scale individual analysis. This tool expands upon the efforts put
forth from other teams who have developed concepts designed to link
omics databases, including peptiogenomics,<sup><xref ref-type="bibr" rid="ref68">68</xref></sup> metabologenomics,<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> and MetaMiner.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup></p></sec></sec><sec id="sec4"><title>Considerations and Challenges</title><p>In principle, there are
no specific limitations to broad adoption
of the approaches and technologies introduced here. Interdisciplinary
training across biological and chemical sciences is essential, as
are strong computational skills. Likewise, the value of cross-disciplinary
collaboration can add paramount value to these studies. However, there
are a number of considerations to the selection of an approach including
the type of genomic data available and the research objective. Many
of the tools and strategies discussed above are amenable to input
from various sequence types, including whole genomes, partial genomes,
metagenomic assemblies, and metagenome-assembled genomes or single
amplified genomes. When considering &#x0201c;big data&#x0201d; and integrating
different data types, the source, type, and completeness must be considered
in any analyses. Completeness can be problematic in cases of phylogenetic
novelty that can influence annotation accuracy and upon analysis of
host-associated microbes which may have undergone genomic streamlining.
Another barrier to analysis occurs during genome assembly, in which
repetitive modules that are often seen in biosynthetic gene clusters
can make assembling the sequences challenging. Long-read technologies
and specialized assembly pipelines can help overcome this obstacle.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup></p><p>Transcriptional regulation of cryptic
BGCs presents a challenge
to linking sequence to product and is a currently active area of research.<sup><xref ref-type="bibr" rid="ref71">71</xref>&#x02212;<xref ref-type="bibr" rid="ref73">73</xref></sup> Identification of an interesting BGC does not necessarily indicate
that the cluster is translated and the product biosynthesized under
laboratory culture conditions. At times, unsilencing of cryptic BGCs
can be promoted through the one strain&#x02013;many compounds (OSMAC)
approach<sup><xref ref-type="bibr" rid="ref74">74</xref></sup> or coculture experiments; however,
at other times, this is an issue best solved at the genome level through
genetic engineering of promoters to control expression in addition
to screening at the levels of gene and protein expression as well.</p><p>As mentioned in brief above, some BGCs, such as terpene synthases
and Type II PKSs, are inherently more challenging to link to their
products due to a lack of colinearity which limits structural prediction.
Likewise, nascent understanding of enzymatic subtypes that catalyze
specific reactions during biosynthesis limit retrobiosynthetic predictions.</p><p>Another hurdle to drug development directly from microbial sources
is that cultivation efforts are not always successful, or if isolated
in pure culture, growth rates can be suboptimal for scale-up. Along
the same lines, heterologous host suitability is an additional consideration.
Finding a genetically tractable host can be difficult&#x02014;particularly
for novel lineages. The repertoire of heterologous hosts is dominated
by <italic>Streptomyces</italic> strains, although is expanding and
currently includes strains of <italic>E. coli</italic>, <italic>Saccharomonspora</italic> sp., <italic>Salinospora</italic> sp., <italic>Pseudoaltermonas</italic> sp., <italic>Anabaena</italic> sp., <italic>Synechococcus</italic> sp., among others.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup></p><p>Lastly, there
are also analytical challenges for compound isolation
and structure elucidation. For example, low natural abundance chemical
analogues identified in a molecular network may preclude subsequent
characterization of the proposed analogue.</p></sec><sec id="sec5"><title>Perspectives and Possible Research Directions</title><p>The rise
of genomic-based workflows for microbial natural product
drug discovery is advancing the field. Genomic approaches for prioritization
of bacteria enriched with biosynthetic pathways and deprioritization
of BGCs known to produce previously identified compounds can help
overcome the hurdle of high rediscovery rates of natural products.
Taxonomy, phylogenetics, and the use of coevolutionary principles
can aid in prioritization of BGCs. Additionally, in order to address
orphan gene clusters or compounds that have not yet been linked to
BGCs, retrobiosynthetic principles can be applied. Analytical metabolomic
tools remain a mainstay in the natural product drug discovery workflows.
Molecular networking is proving to be a powerful tool in identification
of analogues produced by wild-type bacteria as well as from those
engineered to express BGCs of high interest. The linking of paired
genomic and metabolomic data sets will be conducive to large-scale
and small-scale comparative and integrative analyses as natural product
drug discovery efforts continue.</p><p>The field of natural product
drug discovery continues to uncover
novel molecules. The synergy between genomic and metabolomic approaches
realized over the past decade and many of the genomic tools that have
been developed have served to set the stage for a new phase of discovery.
The creation of community-curated repositories for large-scale natural
product data is a powerful and unique contribution to drug discovery
that will continue to promote scientific advancement. As genome sequencing
continues to become more accessible and more affordable, large-scale
sequencing efforts will expand. With this expansion comes opportunity
to pair analytical techniques for natural product discovery with genome-based
approaches. Many of the approaches are currently microbially based;
however, there is need to not only harness the current approaches
with prokaryotes but also to extend into eukaryotic systems.</p><p>One of the primary bottlenecks for drug development of promising
natural products is the issue of supply. The convergence of bacterial
genomics, specifically biosynthetic gene clusters, in the drug discovery
pipeline allows this issue to be addressed by cultivation or heterologous
expression. Barriers beyond limited compound supply include high rediscovery
rates and potential ecological impacts of large sample collections.
These hurdles can be circumnavigated and the deleterious effect ameliorated
by use of these genomic approaches to drug discovery.</p></sec></body><back><notes notes-type="" id="notes-1"><title>Author Present Address</title><p>Nicole
E. Avalon: Center for Marine Biotechnology and Biomedicine, Scripps
Institution of Oceanography, University of California San Diego, La
Jolla, California 92093, United States</p></notes><notes notes-type="" id="notes-2"><title>Author Contributions</title><p>The manuscript
was written through contributions of all authors. All authors have
given approval to the final version of the manuscript.</p></notes><notes notes-type="COI-statement" id="NOTES-d14e629-autogenerated"><p>The authors declare
no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>This work was supported in part by NIH award CA205932 (to
A.E.M. and B.J.B.). The development of our genomics-based workflow
was informed by significant interactions with Patrick S. G. Chain,
Chien-Chi Lo, Hajnalka E. Daligault and Karen W. Davenport from the
Los Alamos National Laboratory, Los Alamos, New Mexico, United States.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Ricke</surname><given-names>D. O.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Cai</surname><given-names>R.</given-names></name>; <name><surname>Cohen</surname><given-names>D.</given-names></name>
<article-title>Genomic approaches
to drug discovery</article-title>. <source>Curr. Opinion Chem. Biol.</source>
<year>2006</year>, <volume>10</volume>, <fpage>303</fpage>&#x02013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2006.06.024</pub-id>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Xia</surname><given-names>X.</given-names></name>
<article-title>Bioinformatics
and Drug Discovery</article-title>. <source>Curr. Top. Med. Chem.</source>
<year>2017</year>, <volume>17</volume>, <fpage>1709</fpage>&#x02013;<lpage>1726</lpage>. <pub-id pub-id-type="doi">10.2174/1568026617666161116143440</pub-id>.<pub-id pub-id-type="pmid">27848897</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Clardy</surname><given-names>J.</given-names></name>; <name><surname>Walsh</surname><given-names>C.</given-names></name>
<article-title>Lessons from natural
molecules</article-title>. <source>Nature</source>
<year>2004</year>, <volume>432</volume>, <fpage>829</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1038/nature03194</pub-id>.<pub-id pub-id-type="pmid">15602548</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Newman</surname><given-names>D. J.</given-names></name>; <name><surname>Cragg</surname><given-names>G. M.</given-names></name>
<article-title>Natural products
as sources of new drugs over the nearly
four decades from 01/1981 to 09/2019</article-title>. <source>J. Nat.
Prod.</source>
<year>2020</year>, <volume>83</volume>, <fpage>770</fpage>&#x02013;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id>.<pub-id pub-id-type="pmid">32162523</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Louwen</surname><given-names>J. J. R.</given-names></name>; <name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></name>
<article-title>Comprehensive large-scale integrative
analysis of omics data to accelerate specialized metabolite discovery</article-title>. <source>mSystems</source>
<year>2021</year>, <volume>6</volume>, <fpage>e0072621</fpage>&#x02013;<lpage>e0072621</lpage>. <pub-id pub-id-type="doi">10.1128/mSystems.00726-21</pub-id>.<pub-id pub-id-type="pmid">34427506</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Chevrette</surname><given-names>M. G.</given-names></name>; <name><surname>Gavrilidou</surname><given-names>A.</given-names></name>; <name><surname>Mantri</surname><given-names>S.</given-names></name>; <name><surname>Selem-Mojica</surname><given-names>N.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>; <name><surname>Barona-G&#x000f3;mez</surname><given-names>F.</given-names></name>
<article-title>The confluence of big data and evolutionary
genome mining for the discovery of natural products</article-title>. <source>Nat. Prod. Rep.</source>
<year>2021</year>, <volume>38</volume>, <fpage>2024</fpage>&#x02013;<lpage>2040</lpage>. <pub-id pub-id-type="doi">10.1039/D1NP00013F</pub-id>.<pub-id pub-id-type="pmid">34787598</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>van
Santen</surname><given-names>J. A.</given-names></name>; <name><surname>Kautsar</surname><given-names>S. A.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Linington</surname><given-names>R. G.</given-names></name>
<article-title>Microbial
natural product databases: moving forward in the multi-omics era</article-title>. <source>Nat. Prod. Rep.</source>
<year>2021</year>, <volume>38</volume>, <fpage>264</fpage>&#x02013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1039/D0NP00053A</pub-id>.<pub-id pub-id-type="pmid">32856641</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Scott</surname><given-names>T. A.</given-names></name>; <name><surname>Piel</surname><given-names>J.</given-names></name>
<article-title>The hidden enzymology of bacterial natural product biosynthesis</article-title>. <source>Nat. Rev. Chem.</source>
<year>2019</year>, <volume>3</volume>, <fpage>404</fpage>&#x02013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1038/s41570-019-0107-1</pub-id>.<pub-id pub-id-type="pmid">32232178</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Schmitt</surname><given-names>I.</given-names></name>; <name><surname>Lumbsch</surname><given-names>H. T.</given-names></name>
<article-title>Ancient horizontal gene transfer
from bacteria enhances
biosynthetic capabilities of fungi</article-title>. <source>PLoS One</source>
<year>2009</year>, <volume>4</volume>, <fpage>e4437</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0004437</pub-id>.<pub-id pub-id-type="pmid">19212443</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Ravenhall</surname><given-names>M.</given-names></name>; <name><surname>&#x00160;kunca</surname><given-names>N.</given-names></name>; <name><surname>Lassalle</surname><given-names>F.</given-names></name>; <name><surname>Dessimoz</surname><given-names>C.</given-names></name>
<article-title>Inferring Horizontal
Gene Transfer</article-title>. <source>PLOS Comp. Biol.</source>
<year>2015</year>, <volume>11</volume>, <fpage>e1004095</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004095</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Chang</surname><given-names>H.-Y.</given-names></name>; <name><surname>Colby</surname><given-names>S. M.</given-names></name>; <name><surname>Du</surname><given-names>X.</given-names></name>; <name><surname>Gomez</surname><given-names>J. D.</given-names></name>; <name><surname>Helf</surname><given-names>M. J.</given-names></name>; <name><surname>Kechris</surname><given-names>K.</given-names></name>; <name><surname>Kirkpatrick</surname><given-names>C. R.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Patti</surname><given-names>G. J.</given-names></name>; <name><surname>Renslow</surname><given-names>R. S.</given-names></name>; <name><surname>Subramaniam</surname><given-names>S.</given-names></name>; <name><surname>Verma</surname><given-names>M.</given-names></name>; <name><surname>Xia</surname><given-names>J.</given-names></name>; <name><surname>Young</surname><given-names>J. D.</given-names></name>
<article-title>A practical guide
to metabolomics software development</article-title>. <source>Anal.
Chem.</source>
<year>2021</year>, <volume>93</volume>, <fpage>1912</fpage>&#x02013;<lpage>1923</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.0c03581</pub-id>.<pub-id pub-id-type="pmid">33467846</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Adamek</surname><given-names>M.</given-names></name>; <name><surname>Alanjary</surname><given-names>M.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>
<article-title>Applied evolution: phylogeny-based
approaches in natural products research</article-title>. <source>Nat.
Prod. Rep.</source>
<year>2019</year>, <volume>36</volume>, <fpage>1295</fpage>&#x02013;<lpage>1312</lpage>. <pub-id pub-id-type="doi">10.1039/C9NP00027E</pub-id>.<pub-id pub-id-type="pmid">31475269</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Albarano</surname><given-names>L.</given-names></name>; <name><surname>Esposito</surname><given-names>R.</given-names></name>; <name><surname>Ruocco</surname><given-names>N.</given-names></name>; <name><surname>Costantini</surname><given-names>M.</given-names></name>
<article-title>Genome mining
as new challenge in natural products discovery</article-title>. <source>Mar. Drugs</source>
<year>2020</year>, <volume>18</volume>, <fpage>199</fpage><pub-id pub-id-type="doi">10.3390/md18040199</pub-id>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Agarwala</surname><given-names>R.</given-names></name>; <name><surname>Barrett</surname><given-names>T.</given-names></name>; <name><surname>Beck</surname><given-names>J.</given-names></name>; <name><surname>Benson</surname><given-names>D. A</given-names></name>; <name><surname>Bollin</surname><given-names>C.</given-names></name>; <name><surname>Bolton</surname><given-names>E.</given-names></name>; <name><surname>Bourexis</surname><given-names>D.</given-names></name>; <name><surname>Brister</surname><given-names>J R.</given-names></name>; <name><surname>Bryant</surname><given-names>S. H</given-names></name>; <name><surname>Canese</surname><given-names>K.</given-names></name>; <name><surname>Cavanaugh</surname><given-names>M.</given-names></name>; <name><surname>Charowhas</surname><given-names>C.</given-names></name>; <name><surname>Clark</surname><given-names>K.</given-names></name>; <name><surname>Dondoshansky</surname><given-names>I.</given-names></name>; <name><surname>Feolo</surname><given-names>M.</given-names></name>; <name><surname>Fitzpatrick</surname><given-names>L.</given-names></name>; <name><surname>Funk</surname><given-names>K.</given-names></name>; <name><surname>Geer</surname><given-names>L. Y</given-names></name>; <name><surname>Gorelenkov</surname><given-names>V.</given-names></name>; <name><surname>Graeff</surname><given-names>A.</given-names></name>; <name><surname>Hlavina</surname><given-names>W.</given-names></name>; <name><surname>Holmes</surname><given-names>B.</given-names></name>; <name><surname>Johnson</surname><given-names>M.</given-names></name>; <name><surname>Kattman</surname><given-names>B.</given-names></name>; <name><surname>Khotomlianski</surname><given-names>V.</given-names></name>; <name><surname>Kimchi</surname><given-names>A.</given-names></name>; <name><surname>Kimelman</surname><given-names>M.</given-names></name>; <name><surname>Kimura</surname><given-names>M.</given-names></name>; <name><surname>Kitts</surname><given-names>P.</given-names></name>; <name><surname>Klimke</surname><given-names>W.</given-names></name>; <name><surname>Kotliarov</surname><given-names>A.</given-names></name>; <name><surname>Krasnov</surname><given-names>S.</given-names></name>; <name><surname>Kuznetsov</surname><given-names>A.</given-names></name>; <name><surname>Landrum</surname><given-names>M. J</given-names></name>; <name><surname>Landsman</surname><given-names>D.</given-names></name>; <name><surname>Lathrop</surname><given-names>S.</given-names></name>; <name><surname>Lee</surname><given-names>J. M</given-names></name>; <name><surname>Leubsdorf</surname><given-names>C.</given-names></name>; <name><surname>Lu</surname><given-names>Z.</given-names></name>; <name><surname>Madden</surname><given-names>T. L</given-names></name>; <name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>; <name><surname>Malheiro</surname><given-names>A.</given-names></name>; <name><surname>Meric</surname><given-names>P.</given-names></name>; <name><surname>Karsch-Mizrachi</surname><given-names>I.</given-names></name>; <name><surname>Mnev</surname><given-names>A.</given-names></name>; <name><surname>Murphy</surname><given-names>T.</given-names></name>; <name><surname>Orris</surname><given-names>R.</given-names></name>; <name><surname>Ostell</surname><given-names>J.</given-names></name>; <name><surname>O'Sullivan</surname><given-names>C.</given-names></name>; <name><surname>Palanigobu</surname><given-names>V.</given-names></name>; <name><surname>Panchenko</surname><given-names>A. R</given-names></name>; <name><surname>Phan</surname><given-names>L.</given-names></name>; <name><surname>Pierov</surname><given-names>B.</given-names></name>; <name><surname>Pruitt</surname><given-names>K. D</given-names></name>; <name><surname>Rodarmer</surname><given-names>K.</given-names></name>; <name><surname>Sayers</surname><given-names>E. W</given-names></name>; <name><surname>Schneider</surname><given-names>V.</given-names></name>; <name><surname>Schoch</surname><given-names>C. L</given-names></name>; <name><surname>Schuler</surname><given-names>G. D</given-names></name>; <name><surname>Sherry</surname><given-names>S. T</given-names></name>; <name><surname>Siyan</surname><given-names>K.</given-names></name>; <name><surname>Soboleva</surname><given-names>A.</given-names></name>; <name><surname>Soussov</surname><given-names>V.</given-names></name>; <name><surname>Starchenko</surname><given-names>G.</given-names></name>; <name><surname>Tatusova</surname><given-names>T. A</given-names></name>; <name><surname>Thibaud-Nissen</surname><given-names>F.</given-names></name>; <name><surname>Todorov</surname><given-names>K.</given-names></name>; <name><surname>Trawick</surname><given-names>B. W</given-names></name>; <name><surname>Vakatov</surname><given-names>D.</given-names></name>; <name><surname>Ward</surname><given-names>M.</given-names></name>; <name><surname>Yaschenko</surname><given-names>E.</given-names></name>; <name><surname>Zasypkin</surname><given-names>A.</given-names></name>; <name><surname>Zbicz</surname><given-names>K.</given-names></name>
<article-title>Database resources
of the National
Center for Biotechnology Information</article-title>. <source>Nucleic
Acids Res.</source>
<year>2018</year>, <volume>46</volume>, <fpage>D8</fpage>&#x02013;<lpage>D13</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1095</pub-id>.<pub-id pub-id-type="pmid">29140470</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Blin</surname><given-names>K.</given-names></name>; <name><surname>Shaw</surname><given-names>S.</given-names></name>; <name><surname>Steinke</surname><given-names>K.</given-names></name>; <name><surname>Villebro</surname><given-names>R.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>; <name><surname>Lee</surname><given-names>S. Y.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Weber</surname><given-names>T.</given-names></name>
<article-title>antiSMASH 5.0: updates
to the secondary metabolite genome mining pipeline</article-title>. <source>Nucleic Acids Res.</source>
<year>2019</year>, <volume>47</volume>, <fpage>W81</fpage>&#x02013;<lpage>W87</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz310</pub-id>.<pub-id pub-id-type="pmid">31032519</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Altschul</surname><given-names>S. F.</given-names></name>; <name><surname>Gish</surname><given-names>W.</given-names></name>; <name><surname>Miller</surname><given-names>W.</given-names></name>; <name><surname>Myers</surname><given-names>E. W.</given-names></name>; <name><surname>Lipman</surname><given-names>D. J.</given-names></name>
<article-title>Basic local
alignment search tool</article-title>. <source>J. Mol. Biol.</source>
<year>1990</year>, <volume>215</volume>, <fpage>403</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id>.<pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Markowitz</surname><given-names>V. M.</given-names></name>; <name><surname>Chen</surname><given-names>I.-M. A.</given-names></name>; <name><surname>Palaniappan</surname><given-names>K.</given-names></name>; <name><surname>Chu</surname><given-names>K.</given-names></name>; <name><surname>Szeto</surname><given-names>E.</given-names></name>; <name><surname>Grechkin</surname><given-names>Y.</given-names></name>; <name><surname>Ratner</surname><given-names>A.</given-names></name>; <name><surname>Jacob</surname><given-names>B.</given-names></name>; <name><surname>Huang</surname><given-names>J.</given-names></name>; <name><surname>Williams</surname><given-names>P.</given-names></name>; <name><surname>Huntemann</surname><given-names>M.</given-names></name>; <name><surname>Anderson</surname><given-names>I.</given-names></name>; <name><surname>Mavromatis</surname><given-names>K.</given-names></name>; <name><surname>Ivanova</surname><given-names>N. N.</given-names></name>; <name><surname>Kyrpides</surname><given-names>N. C.</given-names></name>
<article-title>IMG: the
integrated microbial genomes
database and comparative analysis system</article-title>. <source>Nucleic
Acids Res.</source>
<year>2012</year>, <volume>40</volume>, <fpage>D115</fpage>&#x02013;<lpage>D122</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr1044</pub-id>.<pub-id pub-id-type="pmid">22194640</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J. C.</given-names></name>; <name><surname>Selem-Mojica</surname><given-names>N.</given-names></name>; <name><surname>Mullowney</surname><given-names>M. W.</given-names></name>; <name><surname>Kautsar</surname><given-names>S. A.</given-names></name>; <name><surname>Tryon</surname><given-names>J. H.</given-names></name>; <name><surname>Parkinson</surname><given-names>E. I.</given-names></name>; <name><surname>De Los Santos</surname><given-names>E. L. C.</given-names></name>; <name><surname>Yeong</surname><given-names>M.</given-names></name>; <name><surname>Cruz-Morales</surname><given-names>P.</given-names></name>; <name><surname>Abubucker</surname><given-names>S.</given-names></name>; <name><surname>Roeters</surname><given-names>A.</given-names></name>; <name><surname>Lokhorst</surname><given-names>W.</given-names></name>; <name><surname>Fernandez-Guerra</surname><given-names>A.</given-names></name>; <name><surname>Cappelini</surname><given-names>L. T. D.</given-names></name>; <name><surname>Goering</surname><given-names>A. W.</given-names></name>; <name><surname>Thomson</surname><given-names>R. J.</given-names></name>; <name><surname>Metcalf</surname><given-names>W. W.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>; <name><surname>Barona-Gomez</surname><given-names>F.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>
<article-title>A computational
framework to explore large-scale biosynthetic diversity</article-title>. <source>Nature Chem. Biol.</source>
<year>2020</year>, <volume>16</volume>, <fpage>60</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-019-0400-9</pub-id>.<pub-id pub-id-type="pmid">31768033</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Kautsar</surname><given-names>S. A.</given-names></name>; <name><surname>Blin</surname><given-names>K.</given-names></name>; <name><surname>Shaw</surname><given-names>S.</given-names></name>; <name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J. C.</given-names></name>; <name><surname>Terlouw</surname><given-names>B. R.</given-names></name>; <name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></name>; <name><surname>van Santen</surname><given-names>J. A.</given-names></name>; <name><surname>Tracanna</surname><given-names>V.</given-names></name>; <name><surname>Suarez Duran</surname><given-names>H. G.</given-names></name>; <name><surname>Pascal Andreu</surname><given-names>V.</given-names></name>; et al. <article-title>MIBiG 2.0: a repository for biosynthetic gene clusters of known function</article-title>. <source>Nucleic Acids Res.</source>
<year>2020</year>, <volume>48</volume>, <fpage>D454</fpage>&#x02013;<lpage>D458</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz882</pub-id>.<pub-id pub-id-type="pmid">31612915</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>van
Santen</surname><given-names>J. A.</given-names></name>; <name><surname>Jacob</surname><given-names>G.</given-names></name>; <name><surname>Singh</surname><given-names>A. L.</given-names></name>; <name><surname>Aniebok</surname><given-names>V.</given-names></name>; <name><surname>Balunas</surname><given-names>M. J.</given-names></name>; <name><surname>Bunsko</surname><given-names>D.</given-names></name>; <name><surname>Neto</surname><given-names>F. C.</given-names></name>; <name><surname>Casta&#x000f1;o-Espriu</surname><given-names>L.</given-names></name>; <name><surname>Chang</surname><given-names>C.</given-names></name>; <name><surname>Clark</surname><given-names>T. N.</given-names></name>; et al. <article-title>The Natural Products
Atlas: An open access knowledge base for microbial natural products
discovery</article-title>. <source>ACS Cent. Sci.</source>
<year>2019</year>, <volume>5</volume>, <fpage>1824</fpage>&#x02013;<lpage>1833</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.9b00806</pub-id>.<pub-id pub-id-type="pmid">31807684</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Palaniappan</surname><given-names>K.</given-names></name>; <name><surname>Chen</surname><given-names>I.-M. A.</given-names></name>; <name><surname>Chu</surname><given-names>K.</given-names></name>; <name><surname>Ratner</surname><given-names>A.</given-names></name>; <name><surname>Seshadri</surname><given-names>R.</given-names></name>; <name><surname>Kyrpides</surname><given-names>N. C.</given-names></name>; <name><surname>Ivanova</surname><given-names>N. N.</given-names></name>; <name><surname>Mouncey</surname><given-names>N. J.</given-names></name>
<article-title>IMG-ABC v.5.0: an
update to the IMG/Atlas of Biosynthetic Gene Clusters Knowledgebase</article-title>. <source>Nucleic Acids Res.</source>
<year>2020</year>, <volume>48</volume>, <fpage>D422</fpage>&#x02013;<lpage>D430</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz932</pub-id>.<pub-id pub-id-type="pmid">31665416</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Nayfach</surname><given-names>S.</given-names></name>; <name><surname>Roux</surname><given-names>S.</given-names></name>; <name><surname>Seshadri</surname><given-names>R.</given-names></name>; <name><surname>Udwary</surname><given-names>D.</given-names></name>; <name><surname>Varghese</surname><given-names>N.</given-names></name>; <name><surname>Schulz</surname><given-names>F.</given-names></name>; <name><surname>Wu</surname><given-names>D.</given-names></name>; <name><surname>Paez-Espino</surname><given-names>D.</given-names></name>; <name><surname>Chen</surname><given-names>I. M.</given-names></name>; <name><surname>Huntemann</surname><given-names>M.</given-names></name>; et al. <article-title>A genomic catalog of
Earth&#x02019;s microbiomes</article-title>. <source>Nat. Biotechnol.</source>
<year>2021</year>, <volume>39</volume>, <fpage>499</fpage>&#x02013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-020-0718-6</pub-id>.<pub-id pub-id-type="pmid">33169036</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Murray</surname><given-names>A. E.</given-names></name>; <name><surname>Avalon</surname><given-names>N. E.</given-names></name>; <name><surname>Bishop</surname><given-names>L.</given-names></name>; <name><surname>Davenport</surname><given-names>K. W.</given-names></name>; <name><surname>Delage</surname><given-names>E.</given-names></name>; <name><surname>Dichosa</surname><given-names>A. E. K.</given-names></name>; <name><surname>Eveillard</surname><given-names>D.</given-names></name>; <name><surname>Higham</surname><given-names>M. L.</given-names></name>; <name><surname>Kokkaliari</surname><given-names>S.</given-names></name>; <name><surname>Lo</surname><given-names>C.-C.</given-names></name>; <name><surname>Riesenfeld</surname><given-names>C. S.</given-names></name>; <name><surname>Young</surname><given-names>R. M.</given-names></name>; <name><surname>Chain</surname><given-names>P. S. G.</given-names></name>; <name><surname>Baker</surname><given-names>B. J.</given-names></name>
<article-title>Uncovering the core
microbiome and distribution of palmerolide in <italic>Synoicum adareanum</italic> across the Anvers Island Archipelago, Antarctica</article-title>. <source>Mar. Drugs</source>
<year>2020</year>, <volume>18</volume>, <fpage>298</fpage><pub-id pub-id-type="doi">10.3390/md18060298</pub-id>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Le&#x000e3;o</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>M.</given-names></name>; <name><surname>Moss</surname><given-names>N.</given-names></name>; <name><surname>da Silva</surname><given-names>R.</given-names></name>; <name><surname>Sanders</surname><given-names>J.</given-names></name>; <name><surname>Nurk</surname><given-names>S.</given-names></name>; <name><surname>Gurevich</surname><given-names>A.</given-names></name>; <name><surname>Humphrey</surname><given-names>G.</given-names></name>; <name><surname>Reher</surname><given-names>R.</given-names></name>; <name><surname>Zhu</surname><given-names>Q.</given-names></name>; et al. <article-title>A multi-omics
characterization of the natural product
potential of tropical filamentous marine cyanobacteria</article-title>. <source>Mar. Drugs</source>
<year>2021</year>, <volume>19</volume>, <fpage>20</fpage><pub-id pub-id-type="doi">10.3390/md19010020</pub-id>.<pub-id pub-id-type="pmid">33418911</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Soldatou</surname><given-names>S.</given-names></name>; <name><surname>Eldj&#x000e1;rn</surname><given-names>G. H.</given-names></name>; <name><surname>Ramsay</surname><given-names>A.</given-names></name>; <name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></name>; <name><surname>Hughes</surname><given-names>A. H.</given-names></name>; <name><surname>Rogers</surname><given-names>S.</given-names></name>; <name><surname>Duncan</surname><given-names>K. R.</given-names></name>
<article-title>Comparative metabologenomics
analysis of polar actinomycetes</article-title>. <source>Mar. Drugs</source>
<year>2021</year>, <volume>19</volume>, <fpage>103</fpage><pub-id pub-id-type="doi">10.3390/md19020103</pub-id>.<pub-id pub-id-type="pmid">33578887</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Handayani</surname><given-names>I.</given-names></name>; <name><surname>Saad</surname><given-names>H.</given-names></name>; <name><surname>Ratnakomala</surname><given-names>S.</given-names></name>; <name><surname>Lisdiyanti</surname><given-names>P.</given-names></name>; <name><surname>Kusharyoto</surname><given-names>W.</given-names></name>; <name><surname>Krause</surname><given-names>J.</given-names></name>; <name><surname>Kulik</surname><given-names>A.</given-names></name>; <name><surname>Wohlleben</surname><given-names>W.</given-names></name>; <name><surname>Aziz</surname><given-names>S.</given-names></name>; <name><surname>Gross</surname><given-names>H.</given-names></name>; <name><surname>Gavriilidou</surname><given-names>A.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>; <name><surname>Mast</surname><given-names>Y.</given-names></name>
<article-title>Mining Indonesian microbial biodiversity
for novel natural compounds by a combined genome mining and molecular
networking approach</article-title>. <source>Mar. Drugs</source>
<year>2021</year>, <volume>19</volume>, <fpage>316</fpage><pub-id pub-id-type="doi">10.3390/md19060316</pub-id>.<pub-id pub-id-type="pmid">34071728</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Ziemert</surname><given-names>N.</given-names></name>; <name><surname>Podell</surname><given-names>S.</given-names></name>; <name><surname>Penn</surname><given-names>K.</given-names></name>; <name><surname>Badger</surname><given-names>J. H.</given-names></name>; <name><surname>Allen</surname><given-names>E.</given-names></name>; <name><surname>Jensen</surname><given-names>P. R.</given-names></name>
<article-title>The Natural Product
Domain Seeker NaPDoS: A phylogeny
based bioinformatic Ttool to classify secondary metabolite gene diversity</article-title>. <source>PLoS One</source>
<year>2012</year>, <volume>7</volume>, <fpage>e34064</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0034064</pub-id>.<pub-id pub-id-type="pmid">22479523</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Alanjary</surname><given-names>M.</given-names></name>; <name><surname>Steinke</surname><given-names>K.</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>
<article-title>AutoMLST: an automated web server
for generating multi-locus species trees highlighting natural product
potential</article-title>. <source>Nucleic Acids Res.</source>
<year>2019</year>, <volume>47</volume>, <fpage>W276</fpage>&#x02013;<lpage>W282</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz282</pub-id>.<pub-id pub-id-type="pmid">30997504</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Mungan</surname><given-names>M. D.</given-names></name>; <name><surname>Alanjary</surname><given-names>M.</given-names></name>; <name><surname>Blin</surname><given-names>K.</given-names></name>; <name><surname>Weber</surname><given-names>T.</given-names></name>; <name><surname>Medema</surname><given-names>M. H</given-names></name>; <name><surname>Ziemert</surname><given-names>N.</given-names></name>
<article-title>ARTS 2.0: feature updates
and expansion of the Antibiotic
Resistant Target Seeker for comparative genome mining</article-title>. <source>Nucleic Acids Res.</source>
<year>2020</year>, <volume>48</volume>, <fpage>W546</fpage>&#x02013;<lpage>W552</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa374</pub-id>.<pub-id pub-id-type="pmid">32427317</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Almabruk</surname><given-names>K. H.</given-names></name>; <name><surname>Dinh</surname><given-names>L. K.</given-names></name>; <name><surname>Philmus</surname><given-names>B.</given-names></name>
<article-title>Self-resistance of natural product
producers: Past, present, and future focusing on self-resistant protein
variants</article-title>. <source>ACS Chem. Biol.</source>
<year>2018</year>, <volume>13</volume>, <fpage>1426</fpage>&#x02013;<lpage>1437</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.8b00173</pub-id>.<pub-id pub-id-type="pmid">29763292</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Quir&#x000f3;s</surname><given-names>L. M.</given-names></name>; <name><surname>Aguirrezabalaga</surname><given-names>I.</given-names></name>; <name><surname>Olano</surname><given-names>C.</given-names></name>; <name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name>; <name><surname>Salas</surname><given-names>J. A.</given-names></name>
<article-title>Two glycosyltransferases
and a glycosidase are involved
in oleandomycin modification during its biosynthesis by <italic>Streptomyces</italic> antibioticus</article-title>. <source>Mol. Microbiol.</source>
<year>1998</year>, <volume>28</volume>, <fpage>1177</fpage>&#x02013;<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.1998.00880.x</pub-id>.<pub-id pub-id-type="pmid">9680207</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Wencewicz</surname><given-names>T. A.</given-names></name>
<article-title>Crossroads
of antibiotic resistance and biosynthesis</article-title>. <source>J.
Mol. Biol.</source>
<year>2019</year>, <volume>431</volume>, <fpage>3370</fpage>&#x02013;<lpage>3399</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2019.06.033</pub-id>.<pub-id pub-id-type="pmid">31288031</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>S&#x000e9;lem-Mojica</surname><given-names>N.</given-names></name>; <name><surname>Aguilar</surname><given-names>C.</given-names></name>; <name><surname>Guti&#x000e9;rrez-Garc&#x000ed;a</surname><given-names>K.</given-names></name>; <name><surname>Mart&#x000ed;nez-Guerrero</surname><given-names>C. E.</given-names></name>; <name><surname>Barona-G&#x000f3;mez</surname><given-names>F.</given-names></name>
<article-title>EvoMining
reveals the origin and fate of natural product biosynthetic enzymes</article-title>. <source>Microb. Genom.</source>
<year>2019</year>, <volume>5</volume>, <fpage>e000260</fpage><pub-id pub-id-type="doi">10.1099/mgen.0.000260</pub-id>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Cruz-Morales</surname><given-names>P.</given-names></name>; <name><surname>Kopp</surname><given-names>J. F.</given-names></name>; <name><surname>Mart&#x000ed;nez-Guerrero</surname><given-names>C. E.</given-names></name>; <name><surname>Y&#x000e1;&#x000f1;ez-Guerra</surname><given-names>L. A.</given-names></name>; <name><surname>S&#x000e9;lem-Mojica</surname><given-names>N.</given-names></name>; <name><surname>Ramos-Aboites</surname><given-names>H. E.</given-names></name>; <name><surname>Feldmann</surname><given-names>J.</given-names></name>; <name><surname>Barona-G&#x000f3;mez</surname><given-names>F.</given-names></name>
<article-title>Phylogenomic
analysis of natural products biosynthetic gene clusters allows discovery
of arseno-organic metabolites in model <italic>Streptomycetes</italic></article-title>. <source>Genom. Biol. Evol.</source>
<year>2016</year>, <volume>8</volume>, <fpage>1906</fpage>&#x02013;<lpage>1916</lpage>. <pub-id pub-id-type="doi">10.1093/gbe/evw125</pub-id>.</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>de
Rond</surname><given-names>T.</given-names></name>; <name><surname>Asay</surname><given-names>J. E.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>
<article-title>Co-occurrence of enzyme domains guides
the discovery of an oxazolone synthetase</article-title>. <source>Nature
Chem. Biol.</source>
<year>2021</year>, <volume>17</volume>, <fpage>794</fpage>&#x02013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-021-00808-4</pub-id>.<pub-id pub-id-type="pmid">34099916</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Helfrich</surname><given-names>E. J.</given-names></name>; <name><surname>Piel</surname><given-names>J.</given-names></name>
<article-title>Biosynthesis of polyketides by trans-AT polyketide synthases</article-title>. <source>Nat. Prod. Rep.</source>
<year>2016</year>, <volume>33</volume>, <fpage>231</fpage>&#x02013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1039/C5NP00125K</pub-id>.<pub-id pub-id-type="pmid">26689670</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Cane</surname><given-names>D. E.</given-names></name>; <name><surname>Walsh</surname><given-names>C. T.</given-names></name>; <name><surname>Khosla</surname><given-names>C.</given-names></name>
<article-title>Harnessing the biosynthetic code:
combinations, permutations, and mutations</article-title>. <source>Science</source>
<year>1998</year>, <volume>282</volume>, <fpage>63</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.282.5386.63</pub-id>.<pub-id pub-id-type="pmid">9756477</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Sardar</surname><given-names>D.</given-names></name>; <name><surname>Schmidt</surname><given-names>E. W.</given-names></name>
<article-title>Combinatorial biosynthesis
of RiPPs: docking with marine
life</article-title>. <source>Curr. Opinion Chem. Biol.</source>
<year>2016</year>, <volume>31</volume>, <fpage>15</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2015.11.016</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Montaser</surname><given-names>R.</given-names></name>; <name><surname>Luesch</surname><given-names>H.</given-names></name>
<article-title>Marine natural products:
a new wave of drugs?</article-title>. <source>Future Med. Chem.</source>
<year>2011</year>, <volume>3</volume>, <fpage>1475</fpage>&#x02013;<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.4155/fmc.11.118</pub-id>.<pub-id pub-id-type="pmid">21882941</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Avalon</surname><given-names>N. E.</given-names></name>; <name><surname>Murray</surname><given-names>A. E.</given-names></name>; <name><surname>Daligault</surname><given-names>H. E.</given-names></name>; <name><surname>Lo</surname><given-names>C.-C.</given-names></name>; <name><surname>Davenport</surname><given-names>K. W.</given-names></name>; <name><surname>Dichosa</surname><given-names>A. E. K.</given-names></name>; <name><surname>Chain</surname><given-names>P. S. G.</given-names></name>; <name><surname>Baker</surname><given-names>B. J.</given-names></name>
<article-title>Bioinformatic and
mechanistic analysis of the palmerolide PKS-NRPS biosynthetic pathway
from the microbiome of an Antarctic ascidian</article-title>. <source>Front. Chem.</source>
<year>2021</year>, <volume>9</volume>, <fpage>802574</fpage><pub-id pub-id-type="doi">10.3389/fchem.2021.802574</pub-id>.<pub-id pub-id-type="pmid">35004620</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Murray</surname><given-names>A. E.</given-names></name>; <name><surname>Lo</surname><given-names>C.-C.</given-names></name>; <name><surname>Daligault</surname><given-names>H. E.</given-names></name>; <name><surname>Avalon</surname><given-names>N. E.</given-names></name>; <name><surname>Read</surname><given-names>R. W.</given-names></name>; <name><surname>Davenport</surname><given-names>K. W.</given-names></name>; <name><surname>Higham</surname><given-names>M. L.</given-names></name>; <name><surname>Kunde</surname><given-names>Y.</given-names></name>; <name><surname>Dichosa</surname><given-names>A. E. K.</given-names></name>; <name><surname>Baker</surname><given-names>B. J.</given-names></name>; <name><surname>Chain</surname><given-names>P. S. G.</given-names></name>
<article-title>Discovery of an Antarctic ascidian-associated
uncultivated <italic>Verrucomicrobia</italic> with antimelanoma palmerolide
biosynthetic potential</article-title>. <source>mSphere</source>
<year>2021</year>, <volume>6</volume>, <fpage>e0075921</fpage><pub-id pub-id-type="doi">10.1128/mSphere.00759-21</pub-id>.<pub-id pub-id-type="pmid">34851164</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Suganuma</surname><given-names>M.</given-names></name>; <name><surname>Fujiki</surname><given-names>H.</given-names></name>; <name><surname>Furuya-Suguri</surname><given-names>H.</given-names></name>; <name><surname>Yoshizawa</surname><given-names>S.</given-names></name>; <name><surname>Yasumoto</surname><given-names>S.</given-names></name>; <name><surname>Kato</surname><given-names>Y.</given-names></name>; <name><surname>Fusetani</surname><given-names>N.</given-names></name>; <name><surname>Sugimura</surname><given-names>T.</given-names></name>
<article-title>Calyculin
A, an inhibitor of protein phosphatases, a potent tumor promoter on
CD-1 mouse skin</article-title>. <source>Cancer Res.</source>
<year>1990</year>, <volume>50</volume>, <fpage>3521</fpage>&#x02013;<lpage>3525</lpage>.<pub-id pub-id-type="pmid">2160320</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Wakimoto</surname><given-names>T.</given-names></name>; <name><surname>Egami</surname><given-names>Y.</given-names></name>; <name><surname>Nakashima</surname><given-names>Y.</given-names></name>; <name><surname>Wakimoto</surname><given-names>Y.</given-names></name>; <name><surname>Mori</surname><given-names>T.</given-names></name>; <name><surname>Awakawa</surname><given-names>T.</given-names></name>; <name><surname>Ito</surname><given-names>T.</given-names></name>; <name><surname>Kenmoku</surname><given-names>H.</given-names></name>; <name><surname>Asakawa</surname><given-names>Y.</given-names></name>; <name><surname>Piel</surname><given-names>J.</given-names></name>; <name><surname>Abe</surname><given-names>I.</given-names></name>
<article-title>Calyculin
biogenesis from a pyrophosphate
protoxin produced by a sponge symbiont</article-title>. <source>Nature
Chem. Biol.</source>
<year>2014</year>, <volume>10</volume>, <fpage>648</fpage>&#x02013;<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1573</pub-id>.<pub-id pub-id-type="pmid">24974231</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Jansen</surname><given-names>R.</given-names></name>; <name><surname>H&#x000f6;fle</surname><given-names>G.</given-names></name>; <name><surname>Irschik</surname><given-names>H.</given-names></name>; <name><surname>Reichenbach</surname><given-names>H.</given-names></name>
<article-title>Antibiotika
aus Gleitenden Bakterien, XXIV. Corallopyronin A, B und C &#x02013;
drei neue Antibiotika aus <italic>Corallococcus coralloides</italic> Cc c127 (Myxobacterales)</article-title>. <source>Liebigs Ann. Chem.</source>
<year>1985</year>, <volume>1985</volume>, <fpage>822</fpage>&#x02013;<lpage>836</lpage>. <pub-id pub-id-type="doi">10.1002/jlac.198519850418</pub-id>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Erol</surname><given-names>&#x000d6;.</given-names></name>; <name><surname>Sch&#x000e4;berle</surname><given-names>T. F.</given-names></name>; <name><surname>Schmitz</surname><given-names>A.</given-names></name>; <name><surname>Rachid</surname><given-names>S.</given-names></name>; <name><surname>Gurgui</surname><given-names>C.</given-names></name>; <name><surname>El Omari</surname><given-names>M.</given-names></name>; <name><surname>Lohr</surname><given-names>F.</given-names></name>; <name><surname>Kehraus</surname><given-names>S.</given-names></name>; <name><surname>Piel</surname><given-names>J.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>; <name><surname>K&#x000f6;nig</surname><given-names>G. M.</given-names></name>
<article-title>Biosynthesis
of the myxobacterial antibiotic corallopyronin A</article-title>. <source>ChemBioChem.</source>
<year>2010</year>, <volume>11</volume>, <fpage>1253</fpage>&#x02013;<lpage>1265</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201000085</pub-id>.<pub-id pub-id-type="pmid">20503218</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Sudek</surname><given-names>S.</given-names></name>; <name><surname>Lopanik</surname><given-names>N. B.</given-names></name>; <name><surname>Waggoner</surname><given-names>L. E.</given-names></name>; <name><surname>Hildebrand</surname><given-names>M.</given-names></name>; <name><surname>Anderson</surname><given-names>C.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Patel</surname><given-names>A.</given-names></name>; <name><surname>Sherman</surname><given-names>D. H.</given-names></name>; <name><surname>Haygood</surname><given-names>M. G.</given-names></name>
<article-title>Identification of the putative bryostatin polyketide
synthase gene cluster from &#x0201c;<italic>Candidatus Endobugula sertula</italic>&#x0201d;, the uncultivated microbial symbiont of the marine bryozoan <italic>Bugula neritina</italic></article-title>. <source>J. Nat. Prod.</source>
<year>2007</year>, <volume>70</volume>, <fpage>67</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1021/np060361d</pub-id>.<pub-id pub-id-type="pmid">17253852</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Buchholz</surname><given-names>T. J.</given-names></name>; <name><surname>Rath</surname><given-names>C. M.</given-names></name>; <name><surname>Lopanik</surname><given-names>N. B.</given-names></name>; <name><surname>Gardner</surname><given-names>N. P.</given-names></name>; <name><surname>H&#x000e5;kansson</surname><given-names>K.</given-names></name>; <name><surname>Sherman</surname><given-names>D. H.</given-names></name>
<article-title>Polyketide &#x003b2;-branching
in bryostatin biosynthesis:
Identification of surrogate acetyl-ACP donors for BryR, an HMG-ACP
synthase</article-title>. <source>Chem. Biol.</source>
<year>2010</year>, <volume>17</volume>, <fpage>1092</fpage>&#x02013;<lpage>1100</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2010.08.008</pub-id>.<pub-id pub-id-type="pmid">21035732</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Banerjee</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Mohammad</surname><given-names>M.</given-names></name>; <name><surname>Sarkar</surname><given-names>F. H.</given-names></name>; <name><surname>Mohammad</surname><given-names>R. M.</given-names></name>
<article-title>Efficacy
of selected natural products as therapeutic agents against cancer</article-title>. <source>J. Nat. Prod.</source>
<year>2008</year>, <volume>71</volume>, <fpage>492</fpage>&#x02013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1021/np0705716</pub-id>.<pub-id pub-id-type="pmid">18302335</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Nelson</surname><given-names>T. J.</given-names></name>; <name><surname>Alkon</surname><given-names>D. L.</given-names></name>
<article-title>Neuroprotective versus tumorigenic protein kinase C
activators</article-title>. <source>Trend. Biochem. Sci.</source>
<year>2009</year>, <volume>34</volume>, <fpage>136</fpage>&#x02013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2008.11.006</pub-id>.<pub-id pub-id-type="pmid">19233655</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Sun</surname><given-names>M.-K.</given-names></name>; <name><surname>Alkon</surname><given-names>D. L.</given-names></name>
<article-title>Dual effects of
bryostatin-1 on spatial memory and
depression</article-title>. <source>Eur. J. Pharmacol.</source>
<year>2005</year>, <volume>512</volume>, <fpage>43</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2005.02.028</pub-id>.<pub-id pub-id-type="pmid">15814089</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Wang</surname><given-names>M. X.</given-names></name>; <name><surname>Carver</surname><given-names>J. J.</given-names></name>; <name><surname>Phelan</surname><given-names>V. V.</given-names></name>; <name><surname>Sanchez</surname><given-names>L. M.</given-names></name>; <name><surname>Garg</surname><given-names>N.</given-names></name>; <name><surname>Peng</surname><given-names>Y.</given-names></name>; <name><surname>Nguyen</surname><given-names>D. D.</given-names></name>; <name><surname>Watrous</surname><given-names>J.</given-names></name>; <name><surname>Kapono</surname><given-names>C. A.</given-names></name>; <name><surname>Luzzatto-Knaan</surname><given-names>T.</given-names></name>; et al. <article-title>Sharing and community curation of mass spectrometry
data with Global Natural Products Social Molecular Networking</article-title>. <source>Nat. Biotechnol.</source>
<year>2016</year>, <volume>34</volume>, <fpage>828</fpage>&#x02013;<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3597</pub-id>.<pub-id pub-id-type="pmid">27504778</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Nogawa</surname><given-names>T.</given-names></name>; <name><surname>Terai</surname><given-names>A.</given-names></name>; <name><surname>Amagai</surname><given-names>K.</given-names></name>; <name><surname>Hashimoto</surname><given-names>J.</given-names></name>; <name><surname>Futamura</surname><given-names>Y.</given-names></name>; <name><surname>Okano</surname><given-names>A.</given-names></name>; <name><surname>Fujie</surname><given-names>M.</given-names></name>; <name><surname>Satoh</surname><given-names>N.</given-names></name>; <name><surname>Ikeda</surname><given-names>H.</given-names></name>; <name><surname>Shin-ya</surname><given-names>K.</given-names></name>; <name><surname>Osada</surname><given-names>H.</given-names></name>; <name><surname>Takahashi</surname><given-names>S.</given-names></name>
<article-title>Heterologous
expression of the biosynthetic gene cluster for verticilactam and
identification of analogues</article-title>. <source>J. Nat. Prod.</source>
<year>2020</year>, <volume>83</volume>, <fpage>3598</fpage>&#x02013;<lpage>3605</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c00755</pub-id>.<pub-id pub-id-type="pmid">33216528</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Park</surname><given-names>O.-K.</given-names></name>; <name><surname>Choi</surname><given-names>H.-Y.</given-names></name>; <name><surname>Kim</surname><given-names>G.-W.</given-names></name>; <name><surname>Kim</surname><given-names>W.-G.</given-names></name>
<article-title>Generation of new
complestatin analogues by heterologous expression of the complestatin
biosynthetic gene cluster from <italic>Streptomyces chartreusis</italic> AN1542</article-title>. <source>ChemBioChem.</source>
<year>2016</year>, <volume>17</volume>, <fpage>1725</fpage>&#x02013;<lpage>1731</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201600241</pub-id>.<pub-id pub-id-type="pmid">27383040</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Tan</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Khan</surname><given-names>I.</given-names></name>; <name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name>
<article-title>Heterologous expression
leads to discovery of diversified lobophorin analogues and a fexible
glycosyltransferase</article-title>. <source>Org. Lett.</source>
<year>2020</year>, <volume>22</volume>, <fpage>1062</fpage>&#x02013;<lpage>1066</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.9b04597</pub-id>.<pub-id pub-id-type="pmid">31971807</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Ross</surname><given-names>A. C.</given-names></name>; <name><surname>Gulland</surname><given-names>L. E. S.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>
<article-title>Targeted capture
and heterologous expression of the <italic>Pseudoalteromonas</italic> alterochromide gene cluster in <italic>Escherichia coli</italic> represents a promising natural product exploratory platform</article-title>. <source>ACS Synth. Biol.</source>
<year>2015</year>, <volume>4</volume>, <fpage>414</fpage>&#x02013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1021/sb500280q</pub-id>.<pub-id pub-id-type="pmid">25140825</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Larson</surname><given-names>C. B.</given-names></name>; <name><surname>Cr&#x000fc;semann</surname><given-names>M.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>
<article-title>PCR-independent method of transformation-associated
recombination reveals the cosmomycin biosynthetic gene cluster in
an ocean <italic>Streptomycete</italic></article-title>. <source>J.
Nat. Prod.</source>
<year>2017</year>, <volume>80</volume>, <fpage>1200</fpage>&#x02013;<lpage>1204</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b01121</pub-id>.<pub-id pub-id-type="pmid">28333450</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Gu</surname><given-names>R.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Ren</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Xie</surname><given-names>Y.</given-names></name>; <name><surname>Hong</surname><given-names>B.</given-names></name>
<article-title>Exploring novel herbicidin
analogues by transcriptional regulator overexpression and MS/MS molecular
networking</article-title>. <source>Microb. Cell Factor.</source>
<year>2019</year>, <volume>18</volume>, <fpage>175</fpage><pub-id pub-id-type="doi">10.1186/s12934-019-1225-7</pub-id>.</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Albataineh</surname><given-names>H.</given-names></name>; <name><surname>Duke</surname><given-names>M.</given-names></name>; <name><surname>Misra</surname><given-names>S. K.</given-names></name>; <name><surname>Sharp</surname><given-names>J. S.</given-names></name>; <name><surname>Stevens</surname><given-names>D. C.</given-names></name>
<article-title>Identification
of a solo acylhomoserine lactone synthase from the myxobacterium <italic>Archangium gephyra</italic></article-title>. <source>Sci. Rep.</source>
<year>2021</year>, <volume>11</volume>, <fpage>3018</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-82480-1</pub-id>.<pub-id pub-id-type="pmid">33542315</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Gross</surname><given-names>H.</given-names></name>; <name><surname>Stockwell</surname><given-names>V. O.</given-names></name>; <name><surname>Henkels</surname><given-names>M. D.</given-names></name>; <name><surname>Nowak-Thompson</surname><given-names>B.</given-names></name>; <name><surname>Loper</surname><given-names>J. E.</given-names></name>; <name><surname>Gerwick</surname><given-names>W. H.</given-names></name>
<article-title>The genomisotopic
approach: A systematic
method to isolate products of orphan biosynthetic gene clusters</article-title>. <source>Chem. Biol.</source>
<year>2007</year>, <volume>14</volume>, <fpage>53</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2006.11.007</pub-id>.<pub-id pub-id-type="pmid">17254952</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Kinnel</surname><given-names>R. B.</given-names></name>; <name><surname>Esquenazi</surname><given-names>E.</given-names></name>; <name><surname>Leao</surname><given-names>T.</given-names></name>; <name><surname>Moss</surname><given-names>N.</given-names></name>; <name><surname>Mevers</surname><given-names>E.</given-names></name>; <name><surname>Pereira</surname><given-names>A. R.</given-names></name>; <name><surname>Monroe</surname><given-names>E. A.</given-names></name>; <name><surname>Korobeynikov</surname><given-names>A.</given-names></name>; <name><surname>Murray</surname><given-names>T. F.</given-names></name>; <name><surname>Sherman</surname><given-names>D.</given-names></name>; <name><surname>Gerwick</surname><given-names>L.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>; <name><surname>Gerwick</surname><given-names>W. H.</given-names></name>
<article-title>A maldiisotopic
approach to discover natural products:
Cryptomaldamide, a hybrid tripeptide from the marine cyanobacterium <italic>Moorea producens</italic></article-title>. <source>J. Nat. Prod.</source>
<year>2017</year>, <volume>80</volume>, <fpage>1514</fpage>&#x02013;<lpage>1521</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00019</pub-id>.<pub-id pub-id-type="pmid">28448144</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Taton</surname><given-names>A.</given-names></name>; <name><surname>Ecker</surname><given-names>A.</given-names></name>; <name><surname>Diaz</surname><given-names>B.</given-names></name>; <name><surname>Moss</surname><given-names>N. A.</given-names></name>; <name><surname>Anderson</surname><given-names>B.</given-names></name>; <name><surname>Reher</surname><given-names>R.</given-names></name>; <name><surname>Le&#x000e3;o</surname><given-names>T. F.</given-names></name>; <name><surname>Simkovsky</surname><given-names>R.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>; <name><surname>Gerwick</surname><given-names>L.</given-names></name>; <name><surname>Gerwick</surname><given-names>W. H.</given-names></name>; <name><surname>Golden</surname><given-names>J. W.</given-names></name>
<article-title>Heterologous
expression of cryptomaldamide in a cyanobacterial host</article-title>. <source>ACS Synth. Biol.</source>
<year>2020</year>, <volume>9</volume>, <fpage>3364</fpage>&#x02013;<lpage>3376</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.0c00431</pub-id>.<pub-id pub-id-type="pmid">33180461</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>McCaughey</surname><given-names>C. S.</given-names></name>; <name><surname>van Santen</surname><given-names>J. A.</given-names></name>; <name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Linington</surname><given-names>R. G.</given-names></name>
<article-title>An isotopic
labeling approach linking natural products with biosynthetic gene
clusters</article-title>. <source>Nature Chem. Biol.</source>
<year>2022</year>, <volume>18</volume>, <fpage>295</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-021-00949-6</pub-id>.<pub-id pub-id-type="pmid">34969972</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Behsaz</surname><given-names>B.</given-names></name>; <name><surname>Bode</surname><given-names>E.</given-names></name>; <name><surname>Gurevich</surname><given-names>A.</given-names></name>; <name><surname>Shi</surname><given-names>Y.-N.</given-names></name>; <name><surname>Grundmann</surname><given-names>F.</given-names></name>; <name><surname>Acharya</surname><given-names>D.</given-names></name>; <name><surname>Caraballo-Rodr&#x000ed;guez</surname><given-names>A. M.</given-names></name>; <name><surname>Bouslimani</surname><given-names>A.</given-names></name>; <name><surname>Panitchpakdi</surname><given-names>M.</given-names></name>; <name><surname>Linck</surname><given-names>A.</given-names></name>; <name><surname>Guan</surname><given-names>C.</given-names></name>; <name><surname>Oh</surname><given-names>J.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>; <name><surname>Bode</surname><given-names>H. B.</given-names></name>; <name><surname>Pevzner</surname><given-names>P. A.</given-names></name>; <name><surname>Mohimani</surname><given-names>H.</given-names></name>
<article-title>Integrating
genomics and metabolomics for scalable non-ribosomal peptide discovery</article-title>. <source>Nature Commun.</source>
<year>2021</year>, <volume>12</volume>, <fpage>3225</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-23502-4</pub-id>.<pub-id pub-id-type="pmid">34050176</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Paalvast</surname><given-names>Y.</given-names></name>; <name><surname>Nguyen</surname><given-names>D. D.</given-names></name>; <name><surname>Melnik</surname><given-names>A.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>; <name><surname>Takano</surname><given-names>E.</given-names></name>; <name><surname>Breitling</surname><given-names>R.</given-names></name>
<article-title>Pep2Path: Automated mass spectrometry-guided
genome mining of peptidic natural products</article-title>. <source>PLOS Comp. Biol.</source>
<year>2014</year>, <volume>10</volume>, <fpage>e1003822</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003822</pub-id>.</mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Mohimani</surname><given-names>H.</given-names></name>; <name><surname>Liu</surname><given-names>W.-T.</given-names></name>; <name><surname>Kersten</surname><given-names>R. D.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>; <name><surname>Pevzner</surname><given-names>P. A.</given-names></name>
<article-title>NRPquest: Coupling mass spectrometry and genome mining
for nonribosomal peptide discovery</article-title>. <source>J. Nat.
Prod.</source>
<year>2014</year>, <volume>77</volume>, <fpage>1902</fpage>&#x02013;<lpage>1909</lpage>. <pub-id pub-id-type="doi">10.1021/np500370c</pub-id>.<pub-id pub-id-type="pmid">25116163</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Gurevich</surname><given-names>A.</given-names></name>; <name><surname>Mikheenko</surname><given-names>A.</given-names></name>; <name><surname>Shlemov</surname><given-names>A.</given-names></name>; <name><surname>Korobeynikov</surname><given-names>A.</given-names></name>; <name><surname>Mohimani</surname><given-names>H.</given-names></name>; <name><surname>Pevzner</surname><given-names>P. A.</given-names></name>
<article-title>Increased
diversity of peptidic natural
products revealed by modification-tolerant database search of mass
spectra</article-title>. <source>Nature Microbiol.</source>
<year>2018</year>, <volume>3</volume>, <fpage>319</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-017-0094-2</pub-id>.<pub-id pub-id-type="pmid">29358742</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Schorn</surname><given-names>M. A.</given-names></name>; <name><surname>Verhoeven</surname><given-names>S.</given-names></name>; <name><surname>Ridder</surname><given-names>L.</given-names></name>; <name><surname>Huber</surname><given-names>F.</given-names></name>; <name><surname>Acharya</surname><given-names>D. D.</given-names></name>; <name><surname>Aksenov</surname><given-names>A. A.</given-names></name>; <name><surname>Aleti</surname><given-names>G.</given-names></name>; <name><surname>Moghaddam</surname><given-names>J. A.</given-names></name>; <name><surname>Aron</surname><given-names>A. T.</given-names></name>; <name><surname>Aziz</surname><given-names>S.</given-names></name>; et al. <article-title>A community resource
for paired genomic and metabolomic data mining</article-title>. <source>Nature Chem. Biol.</source>
<year>2021</year>, <volume>17</volume>, <fpage>363</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-020-00724-z</pub-id>.<pub-id pub-id-type="pmid">33589842</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Kersten</surname><given-names>R. D.</given-names></name>; <name><surname>Yang</surname><given-names>Y.-L.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Cimermancic</surname><given-names>P.</given-names></name>; <name><surname>Nam</surname><given-names>S.-J.</given-names></name>; <name><surname>Fenical</surname><given-names>W.</given-names></name>; <name><surname>Fischbach</surname><given-names>M. A.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>
<article-title>A mass spectrometry&#x02013;guided
genome mining approach for natural product peptidogenomics</article-title>. <source>Nature Chem. Biol.</source>
<year>2011</year>, <volume>7</volume>, <fpage>794</fpage>&#x02013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.684</pub-id>.<pub-id pub-id-type="pmid">21983601</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Goering</surname><given-names>A. W.</given-names></name>; <name><surname>McClure</surname><given-names>R. A.</given-names></name>; <name><surname>Doroghazi</surname><given-names>J. R.</given-names></name>; <name><surname>Albright</surname><given-names>J. C.</given-names></name>; <name><surname>Haverland</surname><given-names>N. A.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Ju</surname><given-names>K.-S.</given-names></name>; <name><surname>Thomson</surname><given-names>R. J.</given-names></name>; <name><surname>Metcalf</surname><given-names>W. W.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>
<article-title>Metabologenomics: Correlation of microbial gene clusters
with metabolites drives discovery of a nonribosomal peptide with an
unusual amino acid monomer</article-title>. <source>ACS Cent. Sci.</source>
<year>2016</year>, <volume>2</volume>, <fpage>99</fpage>&#x02013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.5b00331</pub-id>.<pub-id pub-id-type="pmid">27163034</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>Cao</surname><given-names>L.</given-names></name>; <name><surname>Gurevich</surname><given-names>A.</given-names></name>; <name><surname>Alexander</surname><given-names>K. L.</given-names></name>; <name><surname>Naman</surname><given-names>C. B.</given-names></name>; <name><surname>Leao</surname><given-names>T.</given-names></name>; <name><surname>Glukhov</surname><given-names>E.</given-names></name>; <name><surname>Luzzatto-Knaan</surname><given-names>T.</given-names></name>; <name><surname>Vargas</surname><given-names>F.</given-names></name>; <name><surname>Quinn</surname><given-names>R.</given-names></name>; <name><surname>Bouslimani</surname><given-names>A.</given-names></name>; <name><surname>Nothias</surname><given-names>L. F.</given-names></name>; <name><surname>Singh</surname><given-names>N. K.</given-names></name>; <name><surname>Sanders</surname><given-names>J. G.</given-names></name>; <name><surname>Benitez</surname><given-names>R. A.S.</given-names></name>; <name><surname>Thompson</surname><given-names>L. R.</given-names></name>; <name><surname>Hamid</surname><given-names>M.-N.</given-names></name>; <name><surname>Morton</surname><given-names>J. T.</given-names></name>; <name><surname>Mikheenko</surname><given-names>A.</given-names></name>; <name><surname>Shlemov</surname><given-names>A.</given-names></name>; <name><surname>Korobeynikov</surname><given-names>A.</given-names></name>; <name><surname>Friedberg</surname><given-names>I.</given-names></name>; <name><surname>Knight</surname><given-names>R.</given-names></name>; <name><surname>Venkateswaran</surname><given-names>K.</given-names></name>; <name><surname>Gerwick</surname><given-names>W. H.</given-names></name>; <name><surname>Gerwick</surname><given-names>L.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>; <name><surname>Pevzner</surname><given-names>P. A.</given-names></name>; <name><surname>Mohimani</surname><given-names>H.</given-names></name>
<article-title>MetaMiner: A scalable
peptidogenomics
approach for discovery of ribosomal peptide natural products with
blind modifications from microbial communities</article-title>. <source>Cell Systems</source>
<year>2019</year>, <volume>9</volume>, <fpage>600</fpage>&#x02013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1016/j.cels.2019.09.004</pub-id>.<pub-id pub-id-type="pmid">31629686</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>Covington</surname><given-names>B. C.</given-names></name>; <name><surname>Xu</surname><given-names>F.</given-names></name>; <name><surname>Seyedsayamdost</surname><given-names>M. R.</given-names></name>
<article-title>A natural product chemist&#x02019;s
guide to unlocking silent biosynthetic gene clusters</article-title>. <source>Annu. Rev. Biochem.</source>
<year>2021</year>, <volume>90</volume>, <fpage>763</fpage>&#x02013;<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-081420-102432</pub-id>.<pub-id pub-id-type="pmid">33848426</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name><surname>Luo</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Liang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>M.</given-names></name>; <name><surname>Lu</surname><given-names>L.</given-names></name>; <name><surname>Shao</surname><given-names>Z.</given-names></name>; <name><surname>Cobb</surname><given-names>R. E.</given-names></name>; <name><surname>Zhao</surname><given-names>H.</given-names></name>
<article-title>Activation and characterization
of a cryptic polycyclic tetramate macrolactam biosynthetic gene cluster</article-title>. <source>Nature Commun.</source>
<year>2013</year>, <volume>4</volume>, <fpage>2894</fpage><pub-id pub-id-type="doi">10.1038/ncomms3894</pub-id>.<pub-id pub-id-type="pmid">24305602</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name><surname>Yushchuk</surname><given-names>O.</given-names></name>; <name><surname>Ostash</surname><given-names>I.</given-names></name>; <name><surname>M&#x000f6;sker</surname><given-names>E.</given-names></name>; <name><surname>Vlasiuk</surname><given-names>I.</given-names></name>; <name><surname>Deneka</surname><given-names>M.</given-names></name>; <name><surname>R&#x000fc;ckert</surname><given-names>C.</given-names></name>; <name><surname>Busche</surname><given-names>T.</given-names></name>; <name><surname>Fedorenko</surname><given-names>V.</given-names></name>; <name><surname>Kalinowski</surname><given-names>J.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>; <name><surname>Ostash</surname><given-names>B.</given-names></name>
<article-title>Eliciting the silent
lucensomycin biosynthetic pathway in <italic>Streptomyces cyanogenus</italic> S136 via manipulation of the global regulatory gene adpA</article-title>. <source>Sci. Rep.</source>
<year>2021</year>, <volume>11</volume>, <fpage>3507</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-82934-6</pub-id>.<pub-id pub-id-type="pmid">33568768</pub-id></mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name><surname>Bode</surname><given-names>H. B.</given-names></name>; <name><surname>Bethe</surname><given-names>B.</given-names></name>; <name><surname>Hofs</surname><given-names>R.</given-names></name>; <name><surname>Zeeck</surname><given-names>A.</given-names></name>
<article-title>Big effects from small
changes: possible ways to explore nature&#x02019;s chemical diversity</article-title>. <source>Chembiochem</source>
<year>2002</year>, <volume>3</volume>, <fpage>619</fpage>&#x02013;<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1002/1439-7633(20020703)3:7&#x0003c;619::AID-CBIC619&#x0003e;3.0.CO;2-9</pub-id>.<pub-id pub-id-type="pmid">12324995</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name><surname>Wang</surname><given-names>G.</given-names></name>; <name><surname>Zhao</surname><given-names>Z.</given-names></name>; <name><surname>Ke</surname><given-names>J.</given-names></name>; <name><surname>Engel</surname><given-names>Y.</given-names></name>; <name><surname>Shi</surname><given-names>Y.-M.</given-names></name>; <name><surname>Robinson</surname><given-names>D.</given-names></name>; <name><surname>Bingol</surname><given-names>K.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Bowen</surname><given-names>B.</given-names></name>; <name><surname>Louie</surname><given-names>K.</given-names></name>; et al. <article-title>CRAGE
enables rapid activation of biosynthetic gene
clusters in undomesticated bacteria</article-title>. <source>Nature
Microbiol.</source>
<year>2019</year>, <volume>4</volume>, <fpage>2498</fpage>&#x02013;<lpage>2510</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-019-0573-8</pub-id>.<pub-id pub-id-type="pmid">31611640</pub-id></mixed-citation></ref></ref-list></back></article>